🇺🇸 FDA
Patent

US 10646555

Compositions and methods relating to argininosuccinate synthetase

granted A61KA61K38/45A61K38/53

Quick answer

US patent 10646555 (Compositions and methods relating to argininosuccinate synthetase) held by BioRegency, Inc. expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BioRegency, Inc.
Grant date
Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/45, A61K38/53, A61K47/60, A61P